Notice2026-02494
Agency Information Collection Activities: Submission for OMB Review; Comment Request
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 9, 2026
Issuing agencies
Health and Human Services DepartmentSubstance Abuse and Mental Health Services Administration
Full Text
<html>
<head>
<title>Federal Register, Volume 91 Issue 26 (Monday, February 9, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 26 (Monday, February 9, 2026)]
[Notices]
[Pages 5776-5777]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-02494]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and Mental Health Services
Administration (SAMHSA) will publish a summary of information
collection requests under Office of Management and Budget (OMB) review,
in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35).
To request a copy of these documents, email or call the SAMHSA Reports
Clearance Officer at <a href="/cdn-cgi/l/email-protection#196a7874716a78696b78596a7874716a783771716a377e766f"><span class="__cf_email__" data-cfemail="5f2c3e32372c3e2f2d3e1f2c3e32372c3e7137372c71383029">[email protected]</span></a> or (240) 276-0166.
Proposed Project: Program Evaluation for Prevention Contract (PEPC)
Evaluation (OMB No. 0930-0377)--Revision
The Substance Abuse and Mental Health Services Administration's
(SAMHSA) Center for Behavioral Health Statistics and Quality (CBHSQ)
aims to complete a cross-site evaluation of SAMHSA's Strategic
Prevention Framework for Prescription Drugs (SPF Rx). SPF Rx is
designed to address nonmedical use of prescription drugs as well as
opioid overdoses by raising awareness about the dangers of sharing
medications and by working with pharmaceutical and medical communities
on the risks of overprescribing. The SPF Rx program grantees also raise
community awareness and bring activities related to prescription drug
misuse prevention and education to schools, communities, parents,
prescribers, and their patients. The SPF Rx program aims to promote
collaboration between states, tribes, U.S. territories, and
pharmaceutical and medical communities to understand the risks of
overprescribing to youth ages 12-17 and adults 18 years of age and
older. The program also aims to enhance capacity for, and access to,
Prescription Drug Monitoring Program (PDMP) data for prevention
purposes.
This request for data collection includes a revision to previously
approved OMB instruments to allow for data collection through the end
of the grant period with the FY 2021 and FY 2022 grantees. The FY 2021
cohort of grants focused on the dangers of sharing medications; the
risks of overprescribing, especially to young adults; community
awareness and education; and incorporation of PDMP data into grantees'
needs assessments and strategic plans. The FY 2022 cohort of grants
focused on raising awareness about the risks of sharing medications,
taking fake or counterfeit pills, and overprescribing.
The SPF Rx program's indicators of success are reductions in opioid
overdoses, reductions in prescription drug misuse, and improved use of
PDMP data. Data collected through the tools described in this statement
will be used for the national cross-site evaluation of SAMHSA's SPF Rx
program. This request for revision covers continued data collection
through FY 2028 (three years), through the end of the grant period for
grants awarded in FY 2022 and covering the a year of data collection
for an anticipated FY2027 cohort. The Program Evaluation for Prevention
Control (PEPC) team will systematically collect and maintain an Annual
Reporting Tool (ART) and Grantee and Community Level Outcomes data
modules submitted by SPF Rx grantees through the online Data Management
System (DMS), and conduct telephone interviews with SPF Rx grantees.
SAMHSA is requesting approval for data collection for the SPF Rx
cross-site evaluation with the following instruments:
[[Page 5777]]
<bullet> Annual Reporting Tool (ART)--The ART is a survey
instrument collected yearly to monitor state, territory, tribal entity,
and community-level performance, and to evaluate the effectiveness of
the SPF Rx program. This tool is completed by grantees and subrecipient
community project directors and provides process data related to
funding use and effectiveness, organizational capacity, collaboration
with community partners, data infrastructure, planned intervention
targets, evaluation, contextual factors, and sustainability.
<bullet> Grantee-and Community-Level Outcomes Modules--These
modules collect data on key SPF Rx program outcomes, including opioid
prescribing patterns and provider use of PDMP. Grantees will provide
outcomes data at the grantee level for their state, tribal area, or
jurisdiction, as well as at the community level for each of their
subrecipient communities.
<bullet> Grantee-Level Interview--This qualitative interview will
be administered annually to obtain information from the grantee project
directors on their programs, staffing, populations of focus,
infrastructure, capacity, lessons learned, and collaboration.
Average Annualized Data Collection Burden for the PEPC Data Collection \a\
--------------------------------------------------------------------------------------------------------------------------------------------------------
Average Annualized
Average number of Average Hours per Average Hourly data
Instrument number of responses per number of response burden wage c d collection
respondents respondent responses hours burden
--------------------------------------------------------------------------------------------------------------------------------------------------------
ART............................................................. \b\ 107 1 107 1.5 161 $30.56 $4,920.16
\c\ 21 1 21 1.5 31 50.85 1,576.35
---------------------------------------------------------------------------------------
Total Burden for ART........................................ 128 .............. 128 ......... 192 ......... 6,496.51
Grantee-Level PDMP Outcomes Module.............................. \c\ 21 1 21 2.5 52 50.85 2,627.25
Community-Level PDMP Outcomes Module............................ \c\ 21 5.2 107 1.25 134.17 50.85 6,822.38
Grantee-Level Interview......................................... \c\ 21 1 21 1.5 31 50.85 1,576.35
---------------------------------------------------------------------------------------
Total Annualized Burden..................................... 191 .............. 277 ......... 409.17 ......... 17,522.49
--------------------------------------------------------------------------------------------------------------------------------------------------------
\a\ Annualized Data Collection Burden captures the average number of respondents and responses, burden hours, and respondent cost over the 3 years (FY
2026-FY 2028).
\b\ Community subrecipient respondent.
\c\ Grantee respondent.
\d\ Grantee Project Director or Evaluator hourly wage is based on the mean hourly wage for state government managers, as reported in the 2023
Occupational Employment (OES) by the Bureau of Labor Statistics (BLS) found at <a href="https://www.bls.gov/oes/current/naics4_999200.htm#11-00000">https://www.bls.gov/oes/current/naics4_999200.htm#11-00000</a>.
\e\ Subrecipient Staff hourly wage is based on the mean hourly wage for local government counselors, social workers, and other community and social
service specialists, as reported in the 2023 OES by the BLS found at <a href="https://www.bls.gov/oes/current/naics4_999300.htm">https://www.bls.gov/oes/current/naics4_999300.htm</a>.
Written comments and recommendations for the proposed information
collection should be sent within 30 days of publication of this notice
to <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>. Find this particular information
collection by selecting ``Currently under 30-day Review--Open for
Public Comments'' or by using the search function.
Carlos Graham,
Social Science Analyst.
[FR Doc. 2026-02494 Filed 2-6-26; 8:45 am]
BILLING CODE 4162-20-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 9, 2026.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.